Literature DB >> 32429750

Feasibility and Performance of a Gel-Adhesive Pad System for Pediatric Targeted Temperature Management: An Exploratory Analysis of 19 Pediatric Critically Ill Patients.

Alicia M Alcamo1, Rebecca Lavezoli2, Cameron Dezfulian2,3,4, Dennis W Simon2,3,4, Rajesh K Aneja2,3, Robert S B Clark2,3,4, Patrick M Kochanek2,3,4, Ericka L Fink2,3,4.   

Abstract

Targeted temperature management (TTM) is an important treatment modality in pediatric neurocritical care. There are different types of devices available to deliver this therapy, but limited pediatric data exist. This quality improvement study evaluates the use of a surface cooling device that uses gel-adhesive pads for TTM in critically ill pediatric patients. An institutional TTM protocol to use the gel-adhesive pad system was developed with three different temperature goals: normothermia (goal temperature 37°C), mild hypothermia (goal temperature 35°C with rewarming duration of 12 hours to normothermia), and moderate hypothermia (goal temperature 33°C with rewarming duration of 24 hours to normothermia). Protocol and device implementation required several different educational sessions for all members of the critical care team. An exploratory analysis was performed for 19 patients with complete clinical and device temperature data. The most common protocol used was normothermia (73.6%). By protocol, time to goal temperature was 58 minutes (22.0-112.8) for normothermia, 46.5 minutes (44.3-48.8) for mild hypothermia, and 93 minutes (46.5-406.5) for moderate hypothermia. Patients remained within ±0.5°C temperature goal 99% (96.0-99.3) of the time in the normothermia protocol, 99.5% (99-100) in mild hypothermia, and 93% (80-100) for the moderate hypothermia protocol. Shivering was the most common adverse event (35%). Our results show that use of the gel-adhesive pad system for pediatric TTM is feasible, efficacious with regard to achieving both a short time to target temperature and maintaining temperature goal, and, in this limited sample, was free from major adverse events. We also defined several technical aspects of device use in pediatric patients that should be considered in future trial design and/or clinical use. Further studies are needed to determine if this device is superior to other cooling devices for temperature management in the pediatric population.

Entities:  

Keywords:  Arctic Sun; adhesive pads; hypothermia; pediatrics; surface cooling; targeted temperature management

Mesh:

Substances:

Year:  2020        PMID: 32429750      PMCID: PMC7910414          DOI: 10.1089/ther.2020.0011

Source DB:  PubMed          Journal:  Ther Hypothermia Temp Manag        ISSN: 2153-7658            Impact factor:   1.286


  20 in total

Review 1.  Targeted temperature management in critical care: a report and recommendations from five professional societies.

Authors:  Mark E Nunnally; Roman Jaeschke; Geoffrey J Bellingan; Jacques Lacroix; Bruno Mourvillier; Gloria M Rodriguez-Vega; Sten Rubertsson; Theodoros Vassilakopoulos; Craig Weinert; Sergio Zanotti-Cavazzoni; Timothy G Buchman
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

2.  Temperature patterns in the early postresuscitation period after pediatric inhospital cardiac arrest.

Authors:  Melania M Bembea; Vinay M Nadkarni; Marie Diener-West; Vidya Venugopal; Scott M Carey; Robert A Berg; Elizabeth A Hunt
Journal:  Pediatr Crit Care Med       Date:  2010-11       Impact factor: 3.624

3.  Induction and maintenance of therapeutic hypothermia after pediatric cardiac arrest: efficacy of a surface cooling protocol.

Authors:  Alexis Topjian; Larissa Hutchins; Mary Ann DiLiberto; Nicholas S Abend; Rebecca Ichord; Mark Helfaer; Robert A Berg; Vinay Nadkarni
Journal:  Pediatr Crit Care Med       Date:  2011-05       Impact factor: 3.624

4.  Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice.

Authors:  Salam Jarrah; John Dziodzio; Christine Lord; Gilles L Fraser; Lee Lucas; Richard R Riker; David B Seder
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

5.  Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary.

Authors:  Patrick M Kochanek; Robert C Tasker; Nancy Carney; Annette M Totten; P David Adelson; Nathan R Selden; Cynthia Davis-O'Reilly; Erica L Hart; Michael J Bell; Susan L Bratton; Gerald A Grant; Niranjan Kissoon; Karin E Reuter-Rice; Monica S Vavilala; Mark S Wainwright
Journal:  Pediatr Crit Care Med       Date:  2019-03       Impact factor: 3.624

6.  Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes.

Authors:  Abbot Laptook; Jon Tyson; Seetha Shankaran; Scott McDonald; Richard Ehrenkranz; Avroy Fanaroff; Edward Donovan; Ronald Goldberg; T Michael O'Shea; Rosemary D Higgins; W Kenneth Poole
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

7.  Treatment of refractory fever in the neurosciences critical care unit using a novel, water-circulating cooling device. A single-center pilot experience.

Authors:  J Ricardo Carhuapoma; Kapil Gupta; William M Coplin; Salman M Muddassir; Muhammad M Meratee
Journal:  J Neurosurg Anesthesiol       Date:  2003-10       Impact factor: 3.956

8.  Comparison of Two Surface Cooling Devices for Temperature Management in a Neurocritical Care Unit.

Authors:  Gurpreet Singh Aujla; Premkumar Nattanmai; Keerthivaas Premkumar; Christopher R Newey
Journal:  Ther Hypothermia Temp Manag       Date:  2016-12-13       Impact factor: 1.286

9.  Bullous Lesions After Use of a Commercial Therapeutic Hypothermia Temperature Management System: A Possible Burn Injury?

Authors:  Henry E Wang; James M Wells; Dana V Rizk
Journal:  Ther Hypothermia Temp Manag       Date:  2013-09       Impact factor: 1.286

10.  Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system.

Authors:  Nicolas Pichon; Jean Bernard Amiel; Bruno François; Anthony Dugard; Caroline Etchecopar; Philippe Vignon
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.